SS-Chr 5BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
12.16 |
ml/min/g |
0.6 |
1.7 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46651 |
461 |
SS-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
47.71 |
% |
4.02 |
11.37 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47075 |
461 |
SS-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
0.41 |
IU/g |
0.1 |
0.28 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47453 |
461 |
SS-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
0.15 |
IU/g |
0.04 |
0.13 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47309 |
461 |
SS-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
21.9 |
IU/g |
2.48 |
7.45 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48860 |
461 |
SS-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
68.83 |
% |
4.65 |
13.94 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46061 |
461 |
SS-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
39.65 |
% |
4.17 |
12.52 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47072 |
461 |
SS-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
21.25 |
IU/g |
2.13 |
6.4 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48864 |
461 |
SS-Chr 5BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
5.62 |
ml/min/g |
0.6 |
1.81 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46196 |
461 |
SS-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
10 |
|
0.29 |
IU/g |
0.06 |
0.18 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47315 |
461 |
SS-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
30.89 |
IU/g |
3.64 |
10.3 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
45971 |
461 |
SS-Chr 5BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
8.26 |
ml/min/g |
0.72 |
2.15 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46865 |
461 |
SS-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
63.91 |
% |
3.95 |
11.84 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46064 |
461 |
SS-Chr 5BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
|
4.74 |
ml/min/g |
0.44 |
1.33 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46199 |
461 |
SS-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
0.2 |
IU/g |
0.05 |
0.16 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47449 |
461 |
SS-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
23.95 |
IU/g |
2.61 |
7.82 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
45969 |
461 |
SS-Chr 5BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
7.6 |
ml/min/g |
0.55 |
1.73 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46868 |
461 |
SS-Chr 5BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
4.47 |
ml/min/g |
0.63 |
1.88 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44713 |
461 |
SS-Chr 5BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
5.85 |
ml/min/g |
0.63 |
1.79 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44716 |
461 |
SS-Chr 5BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
11.02 |
ml/min/g |
0.65 |
1.95 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46648 |
461 |